基于监测,流行病学和最终结果分析的深度学习模型来预测脑髓母细胞瘤患者的生存率
Meng Sun1, Jikui Sun2, Meng Li3
1Department of Neurosurgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, 250014, Shandong, China.
Scientific reports
|June 24, 2024
概括
深度学习模型,特别是DeepSurv,与CoxPH和RSF等传统方法相比,在预测脑髓母细胞瘤存活率和预后方面提供了更高的准确性.
科学领域:
- 神经瘤学神经瘤学
- 计算生物学 计算生物学
- 生物统计学 生物统计学
背景情况:
- 脑膜母细胞瘤是一种恶性神经上皮瘤,需要准确的预后预测才能有效地实施治疗策略.
- 目前的预后模型需要加强,以改善患者管理.
研究的目的:
- 为了比较深度学习模型 (DeepSurv) 与随机生存森林 (RSF) 和考克斯比例危险 (CoxPH) 模型的预测性能,用于脑髓母细胞瘤预后.
- 评估这些模型在预测患者存活率和周期方面的准确性.
主要方法:
- 来自SEER数据库的2,322名脑髓母细胞瘤患者的大队伍的分析.
- 开发和比较三个不同的生存预测模型:DeepSurv (神经网络),RSF (整体学习) 和CoxPH (传统统计模型).
- 使用随机划分的训练 (70%) 和测试 (30%) 数据集的验证,通过C指数和曲线下面面积 (AUC) 评估预测准确性.
主要成果:
- 与RSF和CoxPH相比,DeepSurv模型表现出更高的C指数 (0.751培训,0.763测试) 的优异性能.
- 在预测1年,3年和5年生存率方面,DeepSurv表现出更高的准确性,AUC值从0.767到0.793.
- 深度学习方法在预测脑髓母细胞瘤患者的生存结果方面更有效.
结论:
- 深度学习算法,以DeepSurv为例,为预测脑髓母细胞瘤预后提供了更准确,更可靠的方法.
- 这种先进的预测能力可以显著帮助量身定制治疗决策并改善患者的治疗结果.
- 该研究强调了人工智能在推进神经瘤学研究和临床实践方面的潜力.
更多相关视频
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
7.2K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
相关概念视频
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
Kaplan-Meier Approach
129
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
129
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
